The impact of Omicron is currently uncertain but it presents a serious challenge that requires preparation for potential decreases in vaccine and treatment efficacy.

“there's reason to have hope and certainly just like the biopharma industry you know fought back you know against the original virus many of us have been anticipating this potential Challenge and that this challenge would go on and on so many of us are trying to be prepared for the worst case scenari”